Skip to player
Skip to main content
Skip to footer
Search
Log in
Sign up
Watch fullscreen
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Benzinga
Follow
Like
Comments
Bookmark
Share
Add to Playlist
Report
7/9/2024
Eli Lilly has come out on top in a weight loss drug competition in a recent study. The study found that patients on Lilly’s Mounjaro lost more weight than those on Novo Nordisk’s Ozempic.
Category
🗞
News
Show less
Recommended
1:19
|
Up next
Oprah Winfrey Tackles Weight Loss Drug Stigma In Prime-Time Special Amid Wegovy-Ozempic Frenzy: 'For 25 Years, Making Fun Of My Weight Was National Sport'
Benzinga
1:20
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Benzinga
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
0:41
Ulta Beauty Stock Climbs On Q4 Earnings Beat: 'Fiscal 2025 Will Be A Pivotal Year'
Benzinga
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
2:34
Disaster Stock Of The Day: Why Dick's Sporting Goods Shares Are Diving Today $DKS
Benzinga
0:39
Two Top Executives Resign as Investigation Links Deaths to Kobayashi Pharmaceutical's Rice Products
Benzinga
2:08
Does The Dip In The S&P500 Indicate A New Downtrend Or Just A Pullback?
Benzinga
4:15
Go Woke, Go Broke, ETF and GUNZ ETF, Matthew Tuttle, Tuttle Capital Management
Benzinga
0:31
GameStop Rockets As Roaring Kitty Returns To X: What Does His Tweet Signal Ahead Of Q3 Earnings?
Benzinga
1:08
As Global Markets Roil, Strategist Soothes Nerves: 'Some Normal Action Under The Surface' As 'Tech Got Way Ahead Of Itself'
Benzinga
15:51
Dee Choubey, Co-Founder and CEO of MoneyLion - $ML
Benzinga
7:13
From Meme to Market: Apu Apustaja's Journey to a $380M Market Cap
Benzinga
0:45
Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock: What Investors Need To Know
Benzinga
6:17
A Deep Dive Analysis Into Nvidia Stock With Wall Street Tech Veteran, Paul Meeks
Benzinga
4:00
Will CrowdStrike Stock Bounce Back?
Benzinga
1:31
Why Is The Fed Still So Aggressive? - Jeremy Schwartz, Chief Investment Officer at WisdomTree
Benzinga
0:38
Jim Cramer Says The 'Shoot First Learn Later' Crowd Got 'Hosed' As Nvidia And Other Tech Stocks Stage Recovery After DeepSeek Turmoil
Benzinga
10:13
Super League Enterprise $SLE Unveils SOUNDZ: A Game-Changer For Brand & Artist Engagement On Roblox
Benzinga